EXAS vs TBRG · rev $2.76B vs P/E 90, rev $342.6M
EXACT Sciences Corporation (EXAS) versus TruBridge Inc. (TBRG) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
TruBridge Inc. (TBRG) is a health information services company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported TBRG revenue for 2024-12-31 was $342.6M. Net income was -$20.4M. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. TBRG currently screens at market cap $391.6M and trailing P/E 90.0.
EXAS currently screens at market cap $20.03B. TBRG currently screens at market cap $391.6M and trailing P/E 90.0.
Not investment advice. Open the EXAS and TBRG stock pages for the full models.
Not investment advice.